In 2020, cannabis experienced significant growth as a result of the COVID-19 pandemic
Billion-dollar cannabis companies on both sides of the border endured declining share values over the past five days of trading.
It’s been a wild ride for investors in three of Canada’s largest cannabis companies.
It’s not often that a publicly traded corporation’s stock increases by more than 100 percent over five trading days.
Find out how investors fared over the week in some high-profile weed companies
Miguel Martin has a track record of running profitable global sales and marketing teams, according to executive chairman Michael Singer
One of the hardest hit companies was Organigram Holdings, whereas Aphria shareholders fared much better
The company has 609 remaining employees, including 433 at its indoor growing facility